首页> 外文期刊>Cancer genomics & proteomics >Modulation of Liver-Intestine Cadherin (Cadherin 17) Expression, ERK Phosphorylation and WNT Signaling in EPHB6 Receptor-expressing MDA-MB-231 Cells
【24h】

Modulation of Liver-Intestine Cadherin (Cadherin 17) Expression, ERK Phosphorylation and WNT Signaling in EPHB6 Receptor-expressing MDA-MB-231 Cells

机译:调节表达EPHB6受体的MDA-MB-231细胞中肝肠钙黏着蛋白(Cadherin 17)的表达,ERK磷酸化和WNT信号传导

获取原文
获取外文期刊封面目录资料

摘要

Aberrant expression of erythropoietin-producing hepatocellular carcinoma cell (EPH) receptors has been reported in a variety of human cancer types. In addition to modulating cell proliferation and migration, EPH receptors are also involved in tumor progression. The transcriptional activation and silencing of EPH receptors are also associated with tumorigenesis. However, the mechanisms underlying the involvement of EPH receptors in tumorigenesis have not been completely deciphered. We have investigated and described the role of EPHB6, a kinase-deficient receptor, in modulating the abundance of cadherin 17 and activation of other intracellular signaling proteins. We previously showed that EPHB6 alters the tumor phenotype of breast carcinoma cells. However, the mechanisms underlying these phenotypic changes had not previously been investigated. Herein we demonstrated the downstream effects of EPHB6 expression on the abundance of cadherin 17, mitogen-activated protein kinase (MEK2), extracellular signal-regulated kinase (ERK), phospho-ERK, {beta}-catenin, phospho- glycogen synthase kinase 3 beta (GSK3{beta}) (ser21/9), cell morphology and actin cytoskeleton. These comparisons were made between EPHB6-deficient MDA-MB-231 cells transfected with an empty pcDNA3 vector and cells stably transfected with an expression construct of EPHB6. The results indicate elevated levels of MEK2 and phospho-ERK. While there was no change in the amount of ERK, the abundance of cadherin 17, {beta}-catenin and phospho-GSK3{beta} was significantly reduced in EPHB6-transfected cells. These studies clearly demonstrate an inverse relationship between the levels of phospho-ERK and the abundance of cadherin 17, {beta}-catenin and phospho-GSK3{beta} in EPHB6-expressing MDA-MB-231 cells. From these data we conclude that EPHB6-mediated alterations arise due to changes in abundance and localization of cadherin 17 and activation of WNT signaling pathway. Transcriptional silencing of EPHB6 in native MDA-MB-231 cells and consequent effects on cadherin 17 and WNT pathway may, thus, be responsible for the invasive behavior of these cells.
机译:已经报道了在多种人类癌症类型中产生促红细胞生成素的肝细胞癌细胞(EPH)受体的异常表达。除了调节细胞增殖和迁移,EPH受体还参与肿瘤的进展。 EPH受体的转录激活和沉默也与肿瘤发生有关。但是,EPH受体参与肿瘤发生的潜在机制尚未完全阐明。我们已经研究和描述了EPHB6(一种激酶缺陷型受体)在调节钙黏着蛋白17的丰度和激活其他细胞内信号蛋白中的作用。我们以前表明,EPHB6改变了乳腺癌细胞的肿瘤表型。但是,这些表型变化的潜在机制以前没有被研究过。在这里,我们证明了EPHB6表达对钙黏着蛋白17,促分裂原激活蛋白激酶(MEK2),细胞外信号调节激酶(ERK),磷酸化ERK,β-连环蛋白,磷酸化糖原合酶激酶3的丰度的下游影响β(GSK3 {beta})(ser21 / 9),细胞形态和肌动蛋白细胞骨架。这些比较是在用空的pcDNA3载体转染的EPHB6缺陷型MDA-MB-231细胞和用EPHB6的表达构建体稳定转染的细胞之间进行的。结果表明MEK2和磷酸化ERK水平升高。虽然ERK的量没有变化,但是在转染了EPHB6的细胞中,钙粘蛋白17,β-连环蛋白和磷酸化GSK3β的丰度明显降低。这些研究清楚地证明了在表达EPHB6的MDA-MB-231细胞中,磷酸化-ERK水平与钙黏着蛋白17,β-连环蛋白和磷酸化-GSK3β的丰度之间存在反比关系。根据这些数据,我们得出结论,EPHB6介导的改变是由于钙黏着蛋白17的丰度和定位变化以及WNT信号通路的激活引起的。因此,天然MDA-MB-231细胞中EPHB6的转录沉默以及对钙黏着蛋白17和WNT途径的影响可能是这些细胞的侵袭行为的原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号